Robert D. Schreiber, PhD

Robert D. Schreiber, PhD is the Andrew M. and Jane M. Bursky Distinguished Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis. He is also professor of molecular microbiology, founding director of the Bursky Center for Human Immunology and Immunotherapy Programs and co-head of the Tumor Immunology Program of the Washington University Siteman Comprehensive Cancer Center. He is a cytokine biologist and tumor immunologist who studies naturally- and therapeutically induced immune responses to cancer with special emphasis on the role of neoantigens as optimal targets for personalized cancer immunotherapy.

During his career, Dr. Schreiber has received many distinguished awards and honors including, among others, the Milstein Award for Outstanding Achievement in Research on Interferons and Cytokines from the International Society for Interferon and Cytokine Research, the Marie T Bonazinga Award for Excellence in Leukocyte Biology Research from Society for Leukocyte Biology, the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology from the Cancer Research Institute, the Charles Rodolphe Brupbacher Prize for Cancer Research, the Balzan Prize, and the Lloyd Old Prize from the American Association for Cancer Research. He is a fellow of the American Association for the Advancement of Science, American Association for Cancer Research Academy, The American Association of Immunologists, and the Academy of Immuno-Oncology of the Society for the Immunotherapy of Cancer. Dr. Schreiber is a member of the National Academy of Sciences, and the American Academy of Arts and Sciences.